Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its First-Quarter Results
Yahoo FinanceMay 4 10:05 ET
Ultragenyx Pharmaceutical(RARE.US) Officer Sells US$15,455.64 in Common Stock
$Ultragenyx Pharmaceutical(RARE.US)$ Officer Crombez Eric sold 354 shares of common stock on May 2, 2024 at an average price of $43.66 for a total value of $15,455.64.Source: Announcement What is stat
moomoo NewsMay 3 16:05 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Ultragenyx Pharmaceutical, Maintains $107 Price Target
BenzingaMay 3 11:14 ET
Earnings Call Summary | Ultragenyx Pharmaceutical(RARE.US) Q1 2024 Earnings Conference
The following is a summary of the Ultragenyx Pharmaceutical, Inc. (RARE) Q1 2024 Earnings Call Transcript:Financial Performance:Ultragenyx reported Q1 2024 revenue of $109 million, with substantial co
moomoo AIMay 3 10:03 ET · Conference Call
Ultragenyx Pharma Is Maintained at Neutral by Wedbush
Ultragenyx Pharma Is Maintained at Neutral by Wedbush
Dow JonesMay 3 09:43 ET
Express News | Ultragenyx Pharmaceutical Inc : Piper Sandler Raises Target Price to $135 From $130
ReutersMay 3 09:37 ET
Express News | Wedbush Maintains Neutral on Ultragenyx Pharmaceutical, Lowers Price Target to $47
BenzingaMay 3 09:33 ET
Truist Financial Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)
TipRanksMay 3 07:30 ET
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Amgen (AMGN) and Zimmer Biomet Holdings (ZBH)
TipRanksMay 3 06:47 ET
Express News | Ultragenyx Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results
BenzingaMay 2 17:23 ET
Express News | Ultragenyx Pharmaceutical Sees FY24 Revenue $500M-$530M Vs $513M Est
BenzingaMay 2 16:01 ET
Earnings Flash (RARE) ULTRAGENYX PHARMACEUTICAL Posts Q1 Revenue $108.8M
04:01 PM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (RARE) ULTRAGENYX PHARMACEUTICAL Posts Q1 Revenue $108.8M
MT NewswiresMay 2 16:01 ET
Express News | Ultragenyx Pharmaceutical Q1 2024 GAAP EPS $(2.03) Misses $(1.77) Estimate, Sales $108.833M Miss $116.009M Estimate
BenzingaMay 2 16:00 ET
Express News | Ultragenyx Pharmaceutical Inc - Reaffirmed 2024 Expected Total Revenue Guidance Between $500 Mln to $530 Mln
ReutersMay 2 16:00 ET
Express News | Ultragenyx Q1 Operating Expenses USD 274 Million
ReutersMay 2 16:00 ET
Express News | Ultragenyx Q1 EPS USD -2.03 Vs. Ibes Estimate USD -1.73
ReutersMay 2 16:00 ET
Ultragenyx Pharma 1Q Loss/Shr $2.03 >RARE
Ultragenyx Pharma 1Q Loss/Shr $2.03 >RARE
Dow JonesMay 2 16:00 ET
Express News | Ultragenyx Q1 Net Income USD -171 Million
ReutersMay 2 16:00 ET
Express News | Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
ReutersMay 2 16:00 ET
Express News | Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusumab (Ux143) for the Treatment of Osteogenesis Imperfecta (Oi)
ReutersApr 30 08:00 ET
No Data
No Data